BCG Vaccine for Intradermal Injection (Lanzhou Institute of Biological Products)

皮内注射用卡介苗（兰州生物制品）

Report date: 2025/04/27 09:13:45

Base Information

Drug NameBCG Vaccine for Intradermal Injection (Lanzhou Institute of Biological Products)
Drug Alias NameBCG vaccine (intradermal)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsTuberculosis
Approved Indications in ChinaTuberculosis
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeL03AX03
Related LinksN/A